FDA gives tentative approval to Mylan's Topamax generic Anderson’s first 100 days spell New Deal for community Rx Although ‘turbulent,’ Rx market up Survey: Patients support getting scripts from doctor Cardinal CEO addresses pressing challenges Novartis' third quarter to reflect $250 million-$300 million charge for Teva litigation McKesson Corp. showcases its strengths at conference Wedgewood Pharmacy technician training program gets approval U.S. Chamber lends support in Medicaid payments battle FDA is looking closely at anemia drug evidence First Previous 1414 1415 1416 1417 1418 Next Last
